PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug to help common bowel disease

2013-10-29
(Press-News.org) Contact information: Dr. Stuart Brierley
stuart.brierley@adelaide.edu.au
61-410-475-625
University of Adelaide
New drug to help common bowel disease An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical studies, and quantified its effectiveness in pain relief in human trials.

Published in the journal Gastroenterology, the study describes the pain mechanism of action for Linaclotide, a recently approved drug for the treatment of chronic abdominal pain and constipation in adult IBS-C patients.

IBS is a potentially debilitating condition with abdominal pain, bloating, diarrhoea and/or constipation. It affects up to 15% of western populations, costing millions of dollars annually in Australia alone in lost productivity and health care. Approximately one third of IBS patients are diagnosed as having IBS-C.

"This is a significant finding and very good news for IBS-C sufferers," says study leader Dr Stuart Brierley, NHMRC RD Wright Biomedical Fellow in the University's Nerve-Gut Research Laboratory. "IBS affects many people, particularly women, on a daily basis and has a significant impact on their quality of life. Abdominal pain is often the most troubling symptom to IBS patients and has been the most difficult symptom to treat.

"The drug is effective in relieving abdominal pain associated with IBS-C and is already available and registered for use by IBS-C patients in the USA and Europe. It is yet to go through the regulatory process in Australia."

The research is a collaboration between the Nerve-Gut Research Laboratory, (University of Adelaide) and Ironwood Pharmaceuticals Inc, the developers of Linaclotide. Linaclotide is a new class of medicine and is the only treatment for IBS-C currently registered with the European Medicines Agency; it is also the first prescription treatment available in over six years for adults with IBS-C in the US.

Linaclotide binds the receptor domain of guanylate cyclase-C on the inner lining of the intestines. It is marketed by Ironwood and Forest Laboratories Inc as Linzess® in the US and by Ironwood and Almirall SA as Constella® in Europe. Ironwood has partnerships through which it is conducting clinical trials of Linaclotide in China and Japan. Ironwood is exploring partnership opportunities for advancing Linaclotide in unpartnered territories, including Australia and New Zealand.

Dr Brierley, in the Nerve-Gut Research Laboratory, collaborated with Ironwood to further investigate how Linaclotide acts within the gastrointestinal tract to reduce abdominal pain. It had been shown to increase the secretion of fluids into the intestine and improve transit through the gastrointestinal tract. However, initial trials had shown that it also reduced abdominal pain associated with IBS-C, independently of its action on improving constipation.

Pre-clinical studies by the Nerve-Gut Research Laboratory showed that Linaclotide inhibits pain nerve endings in the intestine through a novel physiological pathway localised to the gastrointestinal tract. "The study also showed the analgesic effect translated into clinical findings in humans," says Dr Brierley. "IBS-C patients given the drug orally showed significant improvement in abdominal pain over those given placebo during a 26-week trial."

### The research was funded by Ironwood, Forest and the National Health and Medical Research Council of Australia.

Media Contact:

Dr Stuart Brierley
NHMRC RD Wright Biomedical Fellow
Nerve-Gut Research Laboratory
The University of Adelaide
Phone: +61 8 8222 2077
Mobile: +61 410 475 625
stuart.brierley@adelaide.edu.au

Robyn Mills
Media and Communications Officer
The University of Adelaide
Phone: +61 8 8313 6341
Mobile: +61 410 689 084
robyn.mills@adelaide.edu.au


ELSE PRESS RELEASES FROM THIS DATE:

Human immune system shapes skin microbiome

2013-10-29
Human immune system shapes skin microbiome October 29, 2013 -- Our skin plays host to millions of beneficial and potentially disease-causing microorganisms; however, whether our immune system influences these microbial communities to prevent disease is ...

Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer

2013-10-29
Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer WASHINGTON — Like humans, young rats that give birth have a reduced risk of breast cancer later in life. But a new study shows that this protective effect in animals is negated ...

A potential new class of fast-acting antidepressant

2013-10-29
A potential new class of fast-acting antidepressant More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University ...

Extracting energy from bacteria

2013-10-29
Extracting energy from bacteria Most of us wouldn't consider bacteria a promising energy source of the future. That would be shortsighted, says Leonard Tender, a microbial-electrochemist at the Naval Research Laboratory in Washington, D.C., who believes that ...

New forensic technique for identifying cloth fibers

2013-10-29
New forensic technique for identifying cloth fibers Crime-scene investigators may soon have a new tool to help them catch evildoers. Researchers have demonstrated the proof-of-principle for a new forensic technique to identify individual fibers of cloth, which ...

Scientists reduce behaviors associated with problem gambling in rats

2013-10-29
Scientists reduce behaviors associated with problem gambling in rats With the help of a rat casino, University of British Columbia brain researchers have successfully reduced behaviours in rats that are commonly associated with compulsive gambling in humans. The ...

Child sexual abuse via the Internet on the rise

2013-10-29
Child sexual abuse via the Internet on the rise Sexual abuse of children and adolescents can have serious health consequences for victims. Early studies have revealed that child sexual abuse is associated with an increased risk of later mental and physical ...

Scientists gain new insights into dolphin's evolutionary history and conversation

2013-10-29
Scientists gain new insights into dolphin's evolutionary history and conversation October 29, 2013, Shenzhen, China - Researchers from Nanjing Normal University and BGI report their original genomic research on Baiji, also known as Yangtze River dolphin (Lipotes vexillifer). The study gives ...

New study on neurodevelopmental effects of prenatal exposure to paracetamol

2013-10-29
New study on neurodevelopmental effects of prenatal exposure to paracetamol Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. ...

Bats and whales behave in surprisingly similar ways

2013-10-29
Bats and whales behave in surprisingly similar ways Sperm whales weigh up to 50 tons, and the smallest bat barely reaches a gram. Nevertheless, the two species share the same success story: They both have developed the ability to use echolocation - a biological sonar - ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] New drug to help common bowel disease